http://cincluspharma.com/ 2026-01-29T15:24:45+00:00 monthly 1.0 http://cincluspharma.com/about-us/ 2024-05-02T09:22:10+00:00 monthly 0.5 http://cincluspharma.com/about-us/company-strategy/ 2026-01-29T14:03:48+00:00 monthly 0.5 http://cincluspharma.com/about-us/career/ 2026-03-10T08:10:41+00:00 monthly 0.5 http://cincluspharma.com/about-us/career/clinical-research-manager-with-extensive-experience-in-global-phase-iii-clinical-studies/ 2026-03-10T08:12:26+00:00 monthly 0.5 http://cincluspharma.com/about-us/licensed-partners/ 2026-01-29T14:29:34+00:00 monthly 0.5 http://cincluspharma.com/about-us/board-of-directors/ 2026-01-27T14:16:55+00:00 monthly 0.5 http://cincluspharma.com/about-us/management-team/ 2026-03-23T08:05:24+00:00 monthly 0.5 http://cincluspharma.com/our-science/ 2024-05-02T09:17:18+00:00 monthly 0.5 http://cincluspharma.com/our-science/about-gerd/ 2025-10-03T13:54:33+00:00 monthly 0.5 http://cincluspharma.com/our-science/about-gerd/patient-story-life-with-gerd/ 2025-04-01T13:32:11+00:00 monthly 0.5 http://cincluspharma.com/our-science/about-gerd/patient-story-everyday-life-with-gerd/ 2023-01-20T10:47:18+00:00 monthly 0.5 http://cincluspharma.com/our-science/linaprazan-glurate/ 2026-01-29T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/our-science/linaprazan-glurate/ppis-versus-pcabs/ 2025-10-02T14:28:04+00:00 monthly 0.5 http://cincluspharma.com/our-science/development-strategy/ 2025-10-03T08:12:11+00:00 monthly 0.5 http://cincluspharma.com/our-science/clinical-development/ 2025-10-02T14:17:41+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/ 2026-01-27T10:53:16+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/ 2026-01-26T15:04:58+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/clinical-trial-dose-finding-study-of-linaprazan-glurate-a-novel-potassium-competitive-acid-blocker-versus-lansoprazole-for-the-treatment-of-erosive-oesophagitis/ 2026-01-28T15:36:48+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/linaprazan-glurate-is-highly-effective-in-treating-moderate-to-severe-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ueg23_efficacy/ 2026-01-28T15:36:59+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/linaprazan-glurate-is-highly-effective-in-treating-moderate-to-severe-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ddw23/ 2026-01-28T15:37:05+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/linaprazan-glurate-is-well-tolerated-in-the-treatment-of-patients-with-erosive-esophagitis-a-double-blind-randomized-dose-finding-study_abstract-ueg23_safety/ 2026-01-28T15:37:10+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/optimised-biopharmaceutical-and-pharmacokinetic-properties-of-a-linaprazan-glurate-tablet-formulation-to-be-used-in-phase-3_abstract-ueg25/ 2026-01-28T15:37:15+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/optimised-biopharmaceutical-and-pharmacokinetic-properties-of-a-linaprazan-glurate-tablet-formulation-to-be-used-in-phase-3_ddw-25-_pk-abstract/ 2026-01-28T15:37:22+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-after-multiple-oral-doses-up-to-14-days-in-healthy-subjects_abstract-ueg24/ 2026-01-28T15:37:27+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-after-multiple-oral-doses-up-to-14-days-in-healthy-subjects_ddw-25-_pkpd-abstract/ 2026-01-28T15:37:32+00:00 monthly 0.5 http://cincluspharma.com/our-science/scientific-articles/2025/pharmacokinetics-and-pharmacodynamics-of-linaprazan-glurate-aftermultiple-oral-doses-up-to-14-days-in-healthy-subjects_abstract-ddw24/ 2026-01-28T15:37:38+00:00 monthly 0.5 http://cincluspharma.com/media/ 2025-06-11T11:00:45+00:00 monthly 0.5 http://cincluspharma.com/media/press-releases/ 2023-01-13T15:59:39+00:00 monthly 0.5 http://cincluspharma.com/media/press-releases/press-page/ 2023-01-09T14:12:49+00:00 monthly 0.5 http://cincluspharma.com/media/press-releases/disclaimer/ 2024-05-10T13:54:44+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/ 2025-07-02T14:19:28+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/from-summer-job-to-groundbreaking-research/ 2026-03-26T13:34:48+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/magnus-christensen-new-cfo-at-cinclus-pharma/ 2026-03-23T08:33:55+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/clinical-research-manager-with-extensive-experience-in-global-phase-iii-clinical-studies/ 2026-03-09T10:55:54+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/we-welcome-patrik-norgren-as-interim-chief-financial-officer/ 2025-12-16T13:11:32+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-virtual-kol-event-on-healing-the-unhealed/ 2025-12-11T20:17:29+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/ceo-christer-alhberg-presents-at-redeye-life-science-day-2025/ 2025-12-05T15:11:37+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-invites-to-kol-event/ 2025-11-26T09:46:14+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-s-ceo-christer-ahlberg-in-an-interview-with-redeye-about-the-phase-iii-study-and-the-q3-report/ 2025-11-20T16:43:35+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-full-presentation-from-redeye-investor-forum/ 2025-10-13T16:23:24+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-participates-at-redeye-investor-forum-in-gothenburg/ 2025-11-24T14:00:12+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/biotech-tv-interviews-christer-ahlberg/ 2025-09-18T15:05:34+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-aktiedagarna-in-stockholm/ 2025-10-29T09:25:35+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-s-ceo-christer-ahlberg-in-interview-with-efn-ekonomikanalen/ 2025-09-18T15:18:30+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/a-doctor-s-perspective-on-linaprazan-glurate-s-unique-potential/ 2025-07-30T08:00:59+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/nina-rawal-trill-impact-ventures-on-the-investment-in-cinclus-pharma/ 2025-07-16T08:00:23+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/kajsa-larsson-cmo-on-the-upcoming-phase-iii-studies-of-linaprazan-glurate/ 2025-07-10T09:14:23+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/addressing-an-unmet-medical-need-in-gerd/ 2025-08-27T08:00:37+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/a-new-paradigm-shift-driven-by-acid-control/ 2025-09-10T08:00:05+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-presentation-from-biostock-global-forum/ 2025-05-26T16:09:33+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-at-redeye-about-the-partnership-with-zentiva/ 2025-05-22T14:47:56+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-partners-with-zentiva-to-commercialize-linaprazan-glurate-in-europe/ 2025-05-22T07:59:57+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/presentation-at-the-nordea-equities-healthcare-seminar/ 2025-05-08T14:48:51+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-participates-at-biostock-global-forum-in-lund-sweden-may-21/ 2025-05-08T07:36:03+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/bengt-julander-on-cinclus-pharma-in-ditv/ 2024-12-11T16:20:19+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-redeye-technology-life-science-day/ 2024-12-05T11:28:15+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-avanza-s-boersdag/ 2024-11-29T13:31:20+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/nyhetsbyraan-direkt-om-cinclus-pharma/ 2024-11-28T20:04:02+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-stora-aktiedagarna/ 2024-11-28T17:51:09+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-presentation-from-redeye-investor-forum-october-10th/ 2024-10-11T16:11:54+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-redeye-investor-forum-in-gothenburg/ 2024-09-30T11:12:55+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharmas-ceo-christer-ahlberg-interviewed-by-redeye/ 2024-09-25T16:25:45+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-presentation-from-redeye-investor-forum-online-september-19th/ 2024-09-20T09:41:40+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-redeye-investor-forum-online-september-19th/ 2024-09-18T11:16:02+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/watch-the-presentation-from-aktiespararnas-event-september-17th/ 2024-09-18T09:43:37+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-participates-in-aktiespararnas-event-on-september-17th/ 2024-09-18T11:16:26+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/read-the-full-analysis-of-cinclus-pharma-in-the-article-by-boersveckan/ 2024-07-15T09:04:18+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-with-ceo-of-cinclus-pharma-christer-ahlberg-after-the-listing/ 2024-07-12T10:10:20+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-boerspodden/ 2024-06-26T13:46:13+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/highlights-from-todays-ipo-ceremony-at-nasdaq-stockholm/ 2024-06-20T14:29:38+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/strong-interest-in-the-listing-interview-with-ceo-christer-ahlberg/ 2024-06-19T17:47:47+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/first-day-of-trading-in-cinclus-pharma-s-ordinary-shares-on-nasdaq-stockholm/ 2024-06-20T07:44:50+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-with-cinclus-pharmas-ceo-christer-ahlberg-in-boerslunch-on-the-upcoming-listing/ 2024-06-19T15:04:30+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-trading-direkt/ 2024-06-27T14:50:56+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/christer-ahlberg-ceo-of-cinclus-pharma-in-interview-with-nordnet/ 2024-06-19T11:13:41+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-penserpodden/ 2024-06-19T10:59:59+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/presentation-of-the-company-and-the-development-of-linaprazan-glurate-from-redeye-transactions/ 2024-06-14T12:59:41+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/presentation-of-the-company-and-the-development-of-linaprazan-glurate-from-aktiespararnas-event/ 2024-06-13T09:33:11+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-announces-listing-on-nasdaq-stockholm-and-offering-of-ordinary-shares-as-well-as-publishes-related-prospectus/ 2024-06-13T08:59:59+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/christers-presentation-from-redeye-growth-day-2024/ 2024-06-19T16:10:57+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/redeye-growth-day-2024-may-30/ 2024-05-24T12:28:08+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-participates-in-aktiespararnas-event-smaabolagsdagarna-on-june-12/ 2024-05-28T09:37:30+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/abgsc-investor-days/ 2024-05-27T12:18:57+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/presentation-of-the-company-and-the-development-of-linaprazan-glurate-from-avanzas-boersdag/ 2024-06-13T09:22:02+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-participates-at-avanzas-boersdag/ 2024-05-13T15:46:33+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-redeye-investor-forum-in-gothenburg-april-18th-2024/ 2024-09-18T11:18:53+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-presented-at-abgsc-investor-days/ 2023-12-04T15:43:25+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-announces-positive-fda-interaction/ 2023-11-23T08:42:37+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/lennart-hansson-visionary-and-experienced-chairman-of-the-board-of-cinclus-pharma/ 2023-06-30T15:43:23+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-abgsc-life-science-summit-2023/ 2023-06-02T11:47:56+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/nina-rawal-at-trill-impact-ventures-on-the-investment-in-cinclus-pharma/ 2023-05-10T08:12:55+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/malin-filler-senior-regulatory-affairs-manager-with-the-goal-of-getting-linaprazan-glurate-registered-as-an-approved-drug-product/ 2023-05-08T11:50:13+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/kajsa-larsson-experienced-cmo-with-a-focus-on-patient-safety/ 2023-04-14T09:01:13+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/christer-ahlberg-presented-cinclus-pharma-at-stora-aktiedagen-in-stockholm/ 2023-01-12T08:03:50+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/christer-ahlberg-presents-cinclus-pharma-at-stora-aktiedagen-in-gothenburg/ 2023-01-12T08:04:07+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/last-patient-out-lpo-from-the-phase-ii-study-of-linaprazan-glurate/ 2023-01-16T16:40:21+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/goesta-hiller-a-driven-leader-who-wants-to-build-smart-teams-and-see-people-grow-together/ 2023-02-03T12:15:55+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/cinclus-pharma-at-the-abgsc-life-science-summit/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/christer-ahlberg-about-the-present-and-the-future-of-cinclus-pharma/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/life-science-sweden-interviews-kjell-andersson-cso/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/media/in-the-spotlight/improving-the-quality-of-life-for-people-living-with-gerd/ 2023-01-09T14:12:48+00:00 monthly 0.5 http://cincluspharma.com/media/subscribe/ 2023-01-13T16:00:39+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/ 2025-04-02T08:56:16+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/ 2024-04-25T16:31:15+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/christer-ahlberg-ceo/ 2026-02-03T16:09:19+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/goesta-hiller-coo/ 2026-01-30T09:43:53+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/kajsa-larsson-cmo/ 2026-02-03T15:28:15+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/kjell-andersson-non-executive-director-co-founder-cso/ 2026-02-10T10:42:19+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/malin-filler-head-of-regulatory-affairs/ 2026-01-30T09:44:06+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/bengt-erlandsson-head-of-cmc-and-ip/ 2026-01-30T09:44:59+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/peter-wallich-commercial-director/ 2026-02-03T15:28:57+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/lennart-hansson-chairman-of-the-board-co-founder/ 2026-02-10T10:44:00+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/wenche-rolfsen-non-executive-director/ 2026-02-10T10:44:35+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/torbjoern-koivisto-non-executive-director/ 2026-02-10T10:45:37+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/anders-oehberg-non-executive-director/ 2026-02-10T10:46:09+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/helena-levander-non-executive-director/ 2026-02-10T10:46:44+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/nina-rawal-non-executive-director/ 2026-02-10T10:47:23+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/people/magnus-christensen-chief-financial-officer-1/ 2026-03-23T08:22:36+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/logotypes/ 2023-01-09T14:12:50+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/logotypes/cinclus-pharma-logotype/ 2022-05-13T13:34:15+00:00 monthly 0.5 http://cincluspharma.com/media/media-gallery/logotypes/cinclus-pharma-logotype-horizontal/ 2022-05-13T13:34:36+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/ 2025-04-02T08:57:39+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2025/ 2025-01-02T14:26:08+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2025/kjell-andersson-in-the-lonza-podcast-a-view-on-developing-acid-reflux-therapy/ 2025-03-07T14:57:54+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2025/placerase-lists-swedish-stocks-offering-the-biggest-upside/ 2025-01-02T14:27:07+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/ 2024-06-10T10:06:49+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/bengt-julander-on-cinclus-pharma-in-ditv/ 2024-12-11T15:34:45+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/nyhetsbyraan-direkt-about-cinclus-pharma-about-80-90-of-the-potential-for-linaprazan-glurate-in-the-us/ 2024-11-29T11:42:12+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharmas-ceo-christer-ahlberg-interviewed-by-redeye/ 2024-09-25T16:30:42+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-boerspodden/ 2024-09-13T10:00:20+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/christer-ahlberg-ceo-of-cinclus-pharma-participates-in-efn-boerslunch/ 2024-06-18T13:26:09+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-trading-direkt/ 2024-06-18T13:22:00+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/christer-ahlberg-ceo-of-cinclus-pharma-in-an-interview-with-nordnet/ 2024-06-18T10:49:34+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/interview-with-christer-ahlberg-ceo-of-cinclus-pharma-in-penserpodden/ 2024-06-19T10:55:27+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharma-ipo-i-raett-fas/ 2024-06-13T08:54:46+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/laekemedels-vdn-om-noteringen-vi-aer-ett-laagriskprojekt/ 2024-06-11T08:46:27+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharma-till-boersen-foersta-handelsdag-naesta-vecka/ 2024-06-10T17:01:32+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharma-siktar-paa-nasdaq-stockholm/ 2024-06-10T16:56:21+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharma-till-boersen-raeknar-med-godkaent-laekemedel-2029/ 2024-06-10T16:52:39+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/placera-cinclus-pharma-till-boersen/ 2024-06-10T16:49:47+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/cinclus-pharma-holding-ab-plans-to-list-on-nasdaq-inc-in-stockholm-next-week/ 2024-06-17T09:42:26+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2024/dis-information-confirmed-cinclus-pharma-goes-public/ 2024-06-10T10:07:10+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2021/ 2022-11-08T10:03:54+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2021/life-science-sweden-interviews-kjell-andersson-cso/ 2022-11-08T10:06:47+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/ 2022-05-25T08:30:16+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/new-research-advances-for-linc-owned-pharmaceutical-company/ 2022-11-08T10:11:19+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/cinclus-pharma-raises-a-quarter-of-a-billion-sek-eqt-founder-among-investors/ 2022-11-08T10:10:38+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/cinclus-raises-240-million-for-losec-follow-up/ 2022-11-08T10:09:52+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/telegram-bengt-julanders-linc-invests-in-cinclus-pharma-avanza/ 2022-11-08T10:09:02+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/telegram-cinclus-pharma-raises-sek-240-million-realtid/ 2022-11-08T10:09:14+00:00 monthly 0.5 http://cincluspharma.com/media/cinclus-in-media/2022/staahlberg-among-investors-in-stock-market-candidate-that-raises-a-quarter-of-a-billion/ 2022-11-08T10:06:51+00:00 monthly 0.5 http://cincluspharma.com/contact/ 2025-09-09T16:10:36+00:00 monthly 0.5 http://cincluspharma.com/search/ 2021-12-09T18:04:52+00:00 monthly 0.5 http://cincluspharma.com/privacy-policy/ 2026-02-04T11:25:37+00:00 monthly 0.5 http://cincluspharma.com/ipo/ 2024-08-19T14:09:25+00:00 monthly 0.5 http://cincluspharma.com/ipo/download/ 2024-06-10T09:05:58+00:00 monthly 0.5 http://cincluspharma.com/disclaimer/ 2024-06-10T09:20:11+00:00 monthly 0.5